グローバル筋肉内HPVワクチン市場規模、主要企業シェア、ランキング分析レポート【2026年版】
Intramuscular HPV Vaccine - Global Top Players Market Share and Ranking 2026
- レポートID：223927
- 発表時期：2026-03-03
- レポート形式：PDF
- 産業カテゴリー：薬品及びサプリメント
- レポート言語：英語、日本語
- ページ数：128
- 発行会社（調査会社）：YHResearch
言語とエディションの価格
- 英語版
- 日本語版
- 英語と日本語版
個人版詳細
マルチユーザー版詳細
企業版詳細
- 英語版
- 日本語版
- 英語と日本語版
価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=162.40円。
※米ドル表示価格+10％消費税。
※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
レポートの概要
本報告書は、世界の筋肉内HPVワクチン市場について包括的な分析を行い、市場全体の動向を明らかにすることを目的としています。総販売数量、売上高、価格動向に加え、主要企業の市場シェアおよび順位を整理し、市場構造を多角的に把握します。さらに、地域・国別、製品タイプ別、用途分野別などの観点から筋肉内HPVワクチン市場を分析し、需要構造と成長特性を明確化します。
筋肉内HPVワクチン市場の規模、推定値および予測は、2025年を基準年とし、2021年から2032年までの期間における販売数量および売上高に基づいて提示しています。定量分析と定性分析を組み合わせることで、ビジネスおよび成長戦略を検討し、市場競争環境を評価し、企業の市場ポジションを把握した上で、筋肉内HPVワクチンに関する的確な意思決定を行うための実践的なインサイトを提供します。
主要筋肉内HPVワクチン市場の統計
2025年世界市場規模：百万米ドル
2026年世界市場規模：百万米ドル
2032年予測市場規模：百万米ドル
2026–2032年予測期間CAGR：
本レポートは筋肉内HPVワクチン市場の中長期的な成長動向を定量分析および定性分析の両面から体系的に整理しています。
【市場セグメンテーション】
主要企業・競争環境
筋肉内HPVワクチン市場の主要企業には以下が含まれます：
Merck Sharp & Dohme (MSD)
Pfizer
Sanofi
GSK
Serum Institute
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Walvax Biotechnology
Liaoning Chengda Biotechnology
Hualan Biological Engineering
Sinovac Biotech
Chongqing Zhifei Biological Products
Chang Chun High and New Technology Industries (Group)
Beijing Wantai Biological Pharmacy Enterprise
Jiangsu Recbio Technology
製品別
Bivalent
Quadrivalent
Nine-valent
アプリケーション別
Male
Female
レポート対象地域
北米：アメリカ、カナダ、その他
アジア太平洋：中国、日本、韓国、東南アジア、インド、オーストラリア、その他
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、オランダ、北欧諸国、その他
ラテンアメリカ：メキシコ、ブラジル、その他
中東・アフリカ：トルコ、サウジアラビア、UAE、その他
レポート構成（章別概要）
第1章｜市場概要と成長展望
筋肉内HPVワクチン市場の全体像を整理し、市場規模、売上予測、価格推移を体系的に解説します。同時に成長要因、市場機会、業界課題、リスク要因を分析し、中長期的な市場展望を提示します
第2章｜主要企業の競争分析
筋肉内HPVワクチン市場における主要プレイヤー（トップ5社・トップ10社）を対象に、売上高、製造拠点、製品構成、価格戦略、販売量、市場シェアを多面的に分析し、競争構造を明確化します
第3章｜製品カテゴリ別市場動向
製品タイプ別に筋肉内HPVワクチン市場を分類し、売上高、市場シェア、販売量、価格動向を分析します。成長性の高い製品分野と市場構造の変化を明らかにします
第4章｜用途別市場動向
用途別に筋肉内HPVワクチン市場規模、売上高、市場シェア、販売量、価格推移を整理し、業界別の需要動向と成長ポテンシャルを分析します
第5章｜地域別市場分析
地域別の市場成長率、販売量、売上高を詳細に分析し、筋肉内HPVワクチン市場の地理的需要構造を可視化します。各地域の市場規模推移と将来の成長余地を評価します
第6章｜国別市場動向
主要国・地域ごとに、筋肉内HPVワクチン市場の販売量、売上高、成長要因、政策・規制環境、競争特性を整理し、国別市場の特徴を明確にします
第7章｜主要企業プロファイル
筋肉内HPVワクチン市場を牽引する主要企業について、売上高、販売量、価格動向、粗利益率、製品ポートフォリオ、最新の戦略動向を詳細に解説します
第8章｜バリューチェーンと市場構造分析
業界全体のサプライチェーンを上流から下流まで整理し、コスト構造や流通モデルの動向を分析します
第9章｜調査結果
調査結果を総括し、市場全体のトレンド、今後の成長機会、潜在的リスク、戦略的な洞察を提示します
第10章｜付録（調査手法・データソース）
調査設計、分析手法、使用データソースの詳細を明示し、レポートの信頼性と透明性を担保します
本レポートの要点と洞察
筋肉内HPVワクチン市場の全体像と成長見通し
筋肉内HPVワクチン市場の規模変化の傾向、成長予測及び需要動向を体系的に整理いたします。2021年から2025年までの実績データに基づき、2032年までの中長期予測を提示し、市場の拡大速度と成長潜在力を明らかにします。同時に、最近の関税調整措置など各国の政策動向を踏まえ、多角的にグローバル経済環境が筋肉内HPVワクチン市場に与える影響を分析いたします
市場環境の構成要素とマクロトレンド
筋肉内HPVワクチン産業を取り巻く市場環境について、需要構造の変化、政策対応、技術革新の進展といった主要要因を整理します。特に、国際貿易政策や関税政策の変化が企業戦略や価格形成に及ぼす影響、サプライチェーン再編の動きと事業運営への波及効果を明確化し、市場環境の全体像を包括的に提示します
競争構造と主要企業の動向分析
筋肉内HPVワクチン市場における主要企業の売上規模、市場シェア、競争ポジションを整理し、競争構造の特徴を分析します。各社の競争戦略、事業拡大の方向性、新製品・新技術の投入動向を通じて、技術革新が市場競争に与える影響と競争環境の変化を解読します
競争環境と事業動向の把握
製品タイプ別、用途別、地域・国別の観点から筋肉内HPVワクチン市場のセグメント構造を整理します。各地域の需要構成と成長特性を比較分析し、各細分領域が市場全体の成長に与える貢献度と相互関連性を明確にします
成長要因・課題・リスクの分析
筋肉内HPVワクチン市場の成長を支える主要ドライバーを整理するとともに、業界特有の課題や潜在的リスクを分析します。原材料調達、供給システム、事業運営における不確実性を踏まえ、サプライチェーン及び事業レジリエンス強化の方向性についても考察します
将来トレンドと市場展望
筋肉内HPVワクチン市場の中長期的な成長トレンドと将来の発展シナリオを提示します。持続的成長を実現するための重要な成功要因を整理し、今後の市場参入企業や既存プレイヤーの戦略的意思決定に参考となる視点を提供いたします
Description
According to YH Research, the global market for Intramuscular HPV Vaccine should grow from US$ million in 2025 to US$ million by 2032, with a CAGR of %for the period of 2026-2032.
The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.
The intramuscular HPV vaccine is a vaccine to prevent human papillomavirus infection. It boosts the body"s immunity against papillomaviruses by injecting the vaccine into muscle tissue, which triggers an immune response.
The characteristics and precautions of intramuscular injection of HPV vaccine include: recommended age, vaccine dose and vaccination schedule, vaccination site, safety and side effects, catch-up and vaccination recommendations.
This report studies and analyses global Intramuscular HPV Vaccine status and future trends, helps the client to determine the Intramuscular HPV Vaccine market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Intramuscular HPV Vaccine, and provides market size (in Units & US$ million) and Year-over-Year growth, considering 2025 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Intramuscular HPV Vaccine market size, history data 2021-2025, and forecast data 2026-2032, (US$ million) & (Units)
(2) Global Intramuscular HPV Vaccine sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (Units)
(3) Japan Intramuscular HPV Vaccine sales, revenue, price by company, market share and industry ranking 2021-2026, (US$ million) & (Units)
(4) Global Intramuscular HPV Vaccine key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Intramuscular HPV Vaccine key producing regions, capacity, production, and year over year growth
(6) Intramuscular HPV Vaccine industry chains, upstream, midstream and downstream
Market segment by players, this report covers
Merck Sharp & Dohme (MSD)
Pfizer
Sanofi
GSK
Serum Institute
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Walvax Biotechnology
Liaoning Chengda Biotechnology
Hualan Biological Engineering
Sinovac Biotech
Chongqing Zhifei Biological Products
Chang Chun High and New Technology Industries (Group)
Beijing Wantai Biological Pharmacy Enterprise
Jiangsu Recbio Technology
Market segment by Type, covers
Bivalent
Quadrivalent
Nine-valent
Market segment by Application, can be divided into
Male
Female
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Intramuscular HPV Vaccine product scope, global sales quantity, value and average price, Japan sales quantity, value and average price, development opportunities, challenges, trends, and policies
Chapter 2: Global Intramuscular HPV Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 3: Japan Intramuscular HPV Vaccine market share and ranking of major manufacturers, sales quantity, revenue, average price, 2021-2026
Chapter 4: Global key producing regions of Intramuscular HPV Vaccine, percent & CAGR, 2021-2032
Chapter 5: Intramuscular HPV Vaccine industry chain, upstream, medium-stream, and downstream
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2021-2032
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin
Chapter 11: Conclusions
Table of Contents
1 Market Overview
1.1 Intramuscular HPV Vaccine Definition
1.2 Global Intramuscular HPV Vaccine Market Size and Forecast
1.2.1 By Consumption Value, Global Intramuscular HPV Vaccine Market Size, 2021-2032
1.2.2 By Sales Quantity, Global Intramuscular HPV Vaccine Market Size, 2021-2032
1.2.3 Global Intramuscular HPV Vaccine Average Selling Price (ASP), 2021-2032
1.3 Japan Intramuscular HPV Vaccine Market Size and Forecast
1.3.1 By Consumption Value, Japan Intramuscular HPV Vaccine Market Size, 2021-2032
1.3.2 By Sales Quantity, Japan Intramuscular HPV Vaccine Market Size, 2021-2032
1.3.3 Japan Intramuscular HPV Vaccine Average Selling Price (ASP), 2021-2032
1.4 Share of Japan Intramuscular HPV Vaccine Market with Respect to the Global Market
1.4.1 By Consumption Value, Japan Intramuscular HPV Vaccine Market Share in Global, 2021-2032
1.4.2 By Sales Quantity, Japan Intramuscular HPV Vaccine Market Share in Global, 2021-2032
1.4.3 Intramuscular HPV Vaccine Market Size: Japan VS Global, 2021-2032
1.5 Intramuscular HPV Vaccine Market Dynamics
1.5.1 Intramuscular HPV Vaccine Market Drivers
1.5.2 Intramuscular HPV Vaccine Market Restraints
1.5.3 Intramuscular HPV Vaccine Industry Trends
1.5.4 Intramuscular HPV Vaccine Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Intramuscular HPV Vaccine, Global Market Share by Company, 2021-2026
2.2 By Sales Quantity of Intramuscular HPV Vaccine, Global Market Share by Company, 2021-2026
2.3 Intramuscular HPV Vaccine Average Selling Price (ASP) by Company, 2021-2026
2.4 Global Intramuscular HPV Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Intramuscular HPV Vaccine Concentration Ratio
2.6 Global Intramuscular HPV Vaccine Mergers & Acquisitions, Expansion Plans
2.7 Global Intramuscular HPV Vaccine Manufacturers Product Type
2.8 Head Office and Intramuscular HPV Vaccine Production Site of Key Manufacturer
2.9 Intramuscular HPV Vaccine Capacity of Major Manufacturers and Future Plan
3 Japan Leading Manufacturers and Market Share
3.1 By Revenue of Intramuscular HPV Vaccine, Japan Market Share by Company, 2021-2026
3.2 By Sales Quantity of Intramuscular HPV Vaccine, Japan Market Share by Company, 2021-2026
3.3 Japan Intramuscular HPV Vaccine Intramuscular HPV Vaccine Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Intramuscular HPV Vaccine Capacity, Output and Capacity Utilization, 2021-2032
4.2 Global Intramuscular HPV Vaccine Capacity by Region
4.3 Global Intramuscular HPV Vaccine Production & Forecast by Region, 2021 VS 2025 VS 2032
4.4 Global Intramuscular HPV Vaccine Production by Region, 2021-2032
4.5 Global Intramuscular HPV Vaccine Production Market Share & Forecast by Region, 2021-2032
5 Industry Chain Analysis
5.1 Intramuscular HPV Vaccine Industry Chain
5.2 Intramuscular HPV Vaccine Upstream Analysis
5.2.1 Intramuscular HPV Vaccine Core Raw Materials
5.2.2 Main Manufacturers of Intramuscular HPV Vaccine Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Intramuscular HPV Vaccine Production Mode
5.6 Intramuscular HPV Vaccine Procurement Model
5.7 Intramuscular HPV Vaccine Industry Sales Model and Sales Channels
5.7.1 Intramuscular HPV Vaccine Sales Model
5.7.2 Intramuscular HPV Vaccine Typical Distributors
6 Sights by Type
6.1 Intramuscular HPV Vaccine Classification by Type
6.1.1 Bivalent
6.1.2 Quadrivalent
6.1.3 Nine-valent
6.2 by Type, Global Intramuscular HPV Vaccine Consumption Value & CAGR, 2021 VS 2025 VS 2032
6.3 by Type, Global Intramuscular HPV Vaccine Consumption Value, 2021-2032
6.4 by Type, Global Intramuscular HPV Vaccine Sales Quantity, 2021-2032
6.5 by Type, Global Intramuscular HPV Vaccine Average Selling Price (ASP), 2021-2032
7 Sights by Application
7.1 Intramuscular HPV Vaccine Segment by Application
7.1.1 Male
7.1.2 Female
7.2 by Application, Global Intramuscular HPV Vaccine Consumption Value & CAGR, 2021 VS 2025 VS 2032
7.3 by Application, Global Intramuscular HPV Vaccine Consumption Value, 2021-2032
7.4 by Application, Global Intramuscular HPV Vaccine Sales Quantity, 2021-2032
7.5 by Application, Global Intramuscular HPV Vaccine Price, 2021-2032
8 Sales Sights by Region
8.1 By Region, Global Intramuscular HPV Vaccine Consumption Value, 2021 VS 2025 VS 2032
8.2 By Region, Global Intramuscular HPV Vaccine Consumption Value, 2021-2032
8.3 By Region, Global Intramuscular HPV Vaccine Sales Quantity, 2021-2032
8.4 North America
8.4.1 North America Intramuscular HPV Vaccine Market Size & Forecasts, 2021-2032
8.4.2 By Country, North America Intramuscular HPV Vaccine Market Size Market Share
8.5 Europe
8.5.1 Europe Intramuscular HPV Vaccine Market Size & Forecasts, 2021-2032
8.5.2 By Country, Europe Intramuscular HPV Vaccine Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Intramuscular HPV Vaccine Market Size & Forecasts, 2021-2032
8.6.2 By Country/Region, Asia Pacific Intramuscular HPV Vaccine Market Size Market Share
8.7 South America
8.7.1 South America Intramuscular HPV Vaccine Market Size & Forecasts, 2021-2032
8.7.2 By Country, South America Intramuscular HPV Vaccine Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Intramuscular HPV Vaccine Market Size & CAGR, 2021 VS 2025 VS 2032
9.2 By Country, Global Intramuscular HPV Vaccine Consumption Value, 2021-2032
9.3 By Country, Global Intramuscular HPV Vaccine Sales Quantity, 2021-2032
9.4 United States
9.4.1 United States Intramuscular HPV Vaccine Market Size, 2021-2032
9.4.2 by Type, United States Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.4.3 by Application, United States Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.5 Europe
9.5.1 Europe Intramuscular HPV Vaccine Market Size, 2021-2032
9.5.2 by Type, Europe Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.5.3 by Application, Europe Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.6 China
9.6.1 China Intramuscular HPV Vaccine Market Size, 2021-2032
9.6.2 by Type, China Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.6.3 by Application, China Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.7 Japan
9.7.1 Japan Intramuscular HPV Vaccine Market Size, 2021-2032
9.7.2 by Type, Japan Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.7.3 by Application, Japan Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.8 South Korea
9.8.1 South Korea Intramuscular HPV Vaccine Market Size, 2021-2032
9.8.2 by Type, South Korea Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.8.3 by Application, South Korea Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.9 Southeast Asia
9.9.1 Southeast Asia Intramuscular HPV Vaccine Market Size, 2021-2032
9.9.2 by Type, Southeast Asia Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.9.3 by Application, Southeast Asia Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.10 India
9.10.1 India Intramuscular HPV Vaccine Market Size, 2021-2032
9.10.2 by Type, India Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.10.3 by Application, India Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.11 Middle East & Africa
9.11.1 Middle East & Africa Intramuscular HPV Vaccine Market Size, 2021-2032
9.11.2 by Type, Middle East & Africa Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
9.11.3 by Application, Middle East & Africa Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032
10 Manufacturers Profile
10.1 Merck Sharp & Dohme (MSD)
10.1.1 Merck Sharp & Dohme (MSD) Company Information, Head Office, Market Area, and Industry Position
10.1.2 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Models, Specifications, and Application
10.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.1.4 Merck Sharp & Dohme (MSD) Company Profile and Main Business
10.1.5 Merck Sharp & Dohme (MSD) Recent Developments
10.2 Pfizer
10.2.1 Pfizer Company Information, Head Office, Market Area, and Industry Position
10.2.2 Pfizer Intramuscular HPV Vaccine Models, Specifications, and Application
10.2.3 Pfizer Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.2.4 Pfizer Company Profile and Main Business
10.2.5 Pfizer Recent Developments
10.3 Sanofi
10.3.1 Sanofi Company Information, Head Office, Market Area, and Industry Position
10.3.2 Sanofi Intramuscular HPV Vaccine Models, Specifications, and Application
10.3.3 Sanofi Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.3.4 Sanofi Company Profile and Main Business
10.3.5 Sanofi Recent Developments
10.4 GSK
10.4.1 GSK Company Information, Head Office, Market Area, and Industry Position
10.4.2 GSK Intramuscular HPV Vaccine Models, Specifications, and Application
10.4.3 GSK Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.4.4 GSK Company Profile and Main Business
10.4.5 GSK Recent Developments
10.5 Serum Institute
10.5.1 Serum Institute Company Information, Head Office, Market Area, and Industry Position
10.5.2 Serum Institute Intramuscular HPV Vaccine Models, Specifications, and Application
10.5.3 Serum Institute Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.5.4 Serum Institute Company Profile and Main Business
10.5.5 Serum Institute Recent Developments
10.6 Astellas Pharma
10.6.1 Astellas Pharma Company Information, Head Office, Market Area, and Industry Position
10.6.2 Astellas Pharma Intramuscular HPV Vaccine Models, Specifications, and Application
10.6.3 Astellas Pharma Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.6.4 Astellas Pharma Company Profile and Main Business
10.6.5 Astellas Pharma Recent Developments
10.7 CSL
10.7.1 CSL Company Information, Head Office, Market Area, and Industry Position
10.7.2 CSL Intramuscular HPV Vaccine Models, Specifications, and Application
10.7.3 CSL Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.7.4 CSL Company Profile and Main Business
10.7.5 CSL Recent Developments
10.8 Emergent BioSolutions
10.8.1 Emergent BioSolutions Company Information, Head Office, Market Area, and Industry Position
10.8.2 Emergent BioSolutions Intramuscular HPV Vaccine Models, Specifications, and Application
10.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.8.4 Emergent BioSolutions Company Profile and Main Business
10.8.5 Emergent BioSolutions Recent Developments
10.9 GlaxoSmithKline
10.9.1 GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position
10.9.2 GlaxoSmithKline Intramuscular HPV Vaccine Models, Specifications, and Application
10.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.9.4 GlaxoSmithKline Company Profile and Main Business
10.9.5 GlaxoSmithKline Recent Developments
10.10 Johnson & Johnson
10.10.1 Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position
10.10.2 Johnson & Johnson Intramuscular HPV Vaccine Models, Specifications, and Application
10.10.3 Johnson & Johnson Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.10.4 Johnson & Johnson Company Profile and Main Business
10.10.5 Johnson & Johnson Recent Developments
10.11 MedImmune
10.11.1 MedImmune Company Information, Head Office, Market Area, and Industry Position
10.11.2 MedImmune Intramuscular HPV Vaccine Models, Specifications, and Application
10.11.3 MedImmune Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.11.4 MedImmune Company Profile and Main Business
10.11.5 MedImmune Recent Developments
10.12 Walvax Biotechnology
10.12.1 Walvax Biotechnology Company Information, Head Office, Market Area, and Industry Position
10.12.2 Walvax Biotechnology Intramuscular HPV Vaccine Models, Specifications, and Application
10.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.12.4 Walvax Biotechnology Company Profile and Main Business
10.12.5 Walvax Biotechnology Recent Developments
10.13 Liaoning Chengda Biotechnology
10.13.1 Liaoning Chengda Biotechnology Company Information, Head Office, Market Area, and Industry Position
10.13.2 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Models, Specifications, and Application
10.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.13.4 Liaoning Chengda Biotechnology Company Profile and Main Business
10.13.5 Liaoning Chengda Biotechnology Recent Developments
10.14 Hualan Biological Engineering
10.14.1 Hualan Biological Engineering Company Information, Head Office, Market Area, and Industry Position
10.14.2 Hualan Biological Engineering Intramuscular HPV Vaccine Models, Specifications, and Application
10.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.14.4 Hualan Biological Engineering Company Profile and Main Business
10.14.5 Hualan Biological Engineering Recent Developments
10.15 Sinovac Biotech
10.15.1 Sinovac Biotech Company Information, Head Office, Market Area, and Industry Position
10.15.2 Sinovac Biotech Intramuscular HPV Vaccine Models, Specifications, and Application
10.15.3 Sinovac Biotech Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.15.4 Sinovac Biotech Company Profile and Main Business
10.15.5 Sinovac Biotech Recent Developments
10.16 Chongqing Zhifei Biological Products
10.16.1 Chongqing Zhifei Biological Products Company Information, Head Office, Market Area, and Industry Position
10.16.2 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Models, Specifications, and Application
10.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.16.4 Chongqing Zhifei Biological Products Company Profile and Main Business
10.16.5 Chongqing Zhifei Biological Products Recent Developments
10.17 Chang Chun High and New Technology Industries (Group)
10.17.1 Chang Chun High and New Technology Industries (Group) Company Information, Head Office, Market Area, and Industry Position
10.17.2 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Models, Specifications, and Application
10.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.17.4 Chang Chun High and New Technology Industries (Group) Company Profile and Main Business
10.17.5 Chang Chun High and New Technology Industries (Group) Recent Developments
10.18 Beijing Wantai Biological Pharmacy Enterprise
10.18.1 Beijing Wantai Biological Pharmacy Enterprise Company Information, Head Office, Market Area, and Industry Position
10.18.2 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Models, Specifications, and Application
10.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.18.4 Beijing Wantai Biological Pharmacy Enterprise Company Profile and Main Business
10.18.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments
10.19 Jiangsu Recbio Technology
10.19.1 Jiangsu Recbio Technology Company Information, Head Office, Market Area, and Industry Position
10.19.2 Jiangsu Recbio Technology Intramuscular HPV Vaccine Models, Specifications, and Application
10.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales Quantity, Revenue, Price and Gross Margin, 2021-2026
10.19.4 Jiangsu Recbio Technology Company Profile and Main Business
10.19.5 Jiangsu Recbio Technology Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table of Figures
List of Tables Table 1. Intramuscular HPV Vaccine Consumption Value & CAGR: Japan VS Global, 2021-2032, US$ Million Table 2. Intramuscular HPV Vaccine Market Restraints Table 3. Intramuscular HPV Vaccine Market Trends Table 4. Intramuscular HPV Vaccine Industry Policy Table 5. Global Intramuscular HPV Vaccine Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 6. Global Intramuscular HPV Vaccine Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 7. Global Intramuscular HPV Vaccine Sales Quantity by Company, (2021-2026) & (Units), Ranked Based on Sales in 2025 Table 8. Global Intramuscular HPV Vaccine Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025 Table 9. Global Intramuscular HPV Vaccine Average Selling Price (ASP) by Company, (2021-2026) & (US$/Unit) Table 10. Global Intramuscular HPV Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI) Table 11. Global Intramuscular HPV Vaccine Mergers & Acquisitions, Expansion Plans Table 12. Global Intramuscular HPV Vaccine Manufacturers Product Type Table 13. Head Office and Intramuscular HPV Vaccine Production Site of Key Manufacturer Table 14. Intramuscular HPV Vaccine Capacity of Major Manufacturers and Future Plan Table 15. Japan Intramuscular HPV Vaccine Revenue by Company, 2021-2026, US$ million, Ranked Based on Revenue in 2025 Table 16. Japan Intramuscular HPV Vaccine Revenue Share by Company, 2021-2026, Ranked by Data of 2025 Table 17. Japan Intramuscular HPV Vaccine Sales Quantity by Company, (2021-2026) & (Units), Ranked Based on Sales in 2025 Table 18. Japan Intramuscular HPV Vaccine Sales Quantity Market Share by Company, 2021-2026, Ranked by Data of 2025 Table 19. Global Intramuscular HPV Vaccine Production & Forecast by Region, 2021 VS 2025 VS 2032, (Units) Table 20. Global Intramuscular HPV Vaccine Production by Region, 2021-2026, (Units) Table 21. Global Intramuscular HPV Vaccine Production Forecast by Region, 2027-2032, (Units) Table 22. Global Key Players of Intramuscular HPV Vaccine Upstream (Raw Materials) Table 23. Global Intramuscular HPV Vaccine Typical Customers Table 24. Intramuscular HPV Vaccine Typical Distributors Table 25. by Type, Global Intramuscular HPV Vaccine Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 26. by Application, Global Intramuscular HPV Vaccine Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 27. By Region, Global Intramuscular HPV Vaccine Consumption Value, 2021 VS 2025 VS 2032, US$ Million Table 28. By Region, Global Intramuscular HPV Vaccine Consumption Value, 2021-2032, US$ Million Table 29. By Region, Global Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Table 30. By Country, Global Intramuscular HPV Vaccine Consumption Value & CAGR, 2021 VS 2025 VS 2032, US$ Million Table 31. By Country, Global Intramuscular HPV Vaccine Consumption Value, 2021-2032, US$ Million Table 32. By Country, Global Intramuscular HPV Vaccine Consumption Value Market Share, 2021-2032 Table 33. By Country, Global Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Table 34. By Country, Global Intramuscular HPV Vaccine Sales Quantity Market Share, 2021-2032 Table 35. Merck Sharp & Dohme (MSD) Company Information, Head Office, Market Area, and Industry Position Table 36. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Models, Specifications, and Application Table 37. Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 38. Merck Sharp & Dohme (MSD) Company Profile and Main Business Table 39. Merck Sharp & Dohme (MSD) Recent Developments Table 40. Pfizer Company Information, Head Office, Market Area, and Industry Position Table 41. Pfizer Intramuscular HPV Vaccine Models, Specifications, and Application Table 42. Pfizer Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 43. Pfizer Company Profile and Main Business Table 44. Pfizer Recent Developments Table 45. Sanofi Company Information, Head Office, Market Area, and Industry Position Table 46. Sanofi Intramuscular HPV Vaccine Models, Specifications, and Application Table 47. Sanofi Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 48. Sanofi Company Profile and Main Business Table 49. Sanofi Recent Developments Table 50. GSK Company Information, Head Office, Market Area, and Industry Position Table 51. GSK Intramuscular HPV Vaccine Models, Specifications, and Application Table 52. GSK Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 53. GSK Company Profile and Main Business Table 54. GSK Recent Developments Table 55. Serum Institute Company Information, Head Office, Market Area, and Industry Position Table 56. Serum Institute Intramuscular HPV Vaccine Models, Specifications, and Application Table 57. Serum Institute Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 58. Serum Institute Company Profile and Main Business Table 59. Serum Institute Recent Developments Table 60. Astellas Pharma Company Information, Head Office, Market Area, and Industry Position Table 61. Astellas Pharma Intramuscular HPV Vaccine Models, Specifications, and Application Table 62. Astellas Pharma Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 63. Astellas Pharma Company Profile and Main Business Table 64. Astellas Pharma Recent Developments Table 65. CSL Company Information, Head Office, Market Area, and Industry Position Table 66. CSL Intramuscular HPV Vaccine Models, Specifications, and Application Table 67. CSL Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 68. CSL Company Profile and Main Business Table 69. CSL Recent Developments Table 70. Emergent BioSolutions Company Information, Head Office, Market Area, and Industry Position Table 71. Emergent BioSolutions Intramuscular HPV Vaccine Models, Specifications, and Application Table 72. Emergent BioSolutions Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 73. Emergent BioSolutions Company Profile and Main Business Table 74. Emergent BioSolutions Recent Developments Table 75. GlaxoSmithKline Company Information, Head Office, Market Area, and Industry Position Table 76. GlaxoSmithKline Intramuscular HPV Vaccine Models, Specifications, and Application Table 77. GlaxoSmithKline Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 78. GlaxoSmithKline Company Profile and Main Business Table 79. GlaxoSmithKline Recent Developments Table 80. Johnson & Johnson Company Information, Head Office, Market Area, and Industry Position Table 81. Johnson & Johnson Intramuscular HPV Vaccine Models, Specifications, and Application Table 82. Johnson & Johnson Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 83. Johnson & Johnson Company Profile and Main Business Table 84. Johnson & Johnson Recent Developments Table 85. MedImmune Company Information, Head Office, Market Area, and Industry Position Table 86. MedImmune Intramuscular HPV Vaccine Models, Specifications, and Application Table 87. MedImmune Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 88. MedImmune Company Profile and Main Business Table 89. MedImmune Recent Developments Table 90. Walvax Biotechnology Company Information, Head Office, Market Area, and Industry Position Table 91. Walvax Biotechnology Intramuscular HPV Vaccine Models, Specifications, and Application Table 92. Walvax Biotechnology Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 93. Walvax Biotechnology Company Profile and Main Business Table 94. Walvax Biotechnology Recent Developments Table 95. Liaoning Chengda Biotechnology Company Information, Head Office, Market Area, and Industry Position Table 96. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Models, Specifications, and Application Table 97. Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 98. Liaoning Chengda Biotechnology Company Profile and Main Business Table 99. Liaoning Chengda Biotechnology Recent Developments Table 100. Hualan Biological Engineering Company Information, Head Office, Market Area, and Industry Position Table 101. Hualan Biological Engineering Intramuscular HPV Vaccine Models, Specifications, and Application Table 102. Hualan Biological Engineering Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 103. Hualan Biological Engineering Company Profile and Main Business Table 104. Hualan Biological Engineering Recent Developments Table 105. Sinovac Biotech Company Information, Head Office, Market Area, and Industry Position Table 106. Sinovac Biotech Intramuscular HPV Vaccine Models, Specifications, and Application Table 107. Sinovac Biotech Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 108. Sinovac Biotech Company Profile and Main Business Table 109. Sinovac Biotech Recent Developments Table 110. Chongqing Zhifei Biological Products Company Information, Head Office, Market Area, and Industry Position Table 111. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Models, Specifications, and Application Table 112. Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 113. Chongqing Zhifei Biological Products Company Profile and Main Business Table 114. Chongqing Zhifei Biological Products Recent Developments Table 115. Chang Chun High and New Technology Industries (Group) Company Information, Head Office, Market Area, and Industry Position Table 116. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Models, Specifications, and Application Table 117. Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 118. Chang Chun High and New Technology Industries (Group) Company Profile and Main Business Table 119. Chang Chun High and New Technology Industries (Group) Recent Developments Table 120. Beijing Wantai Biological Pharmacy Enterprise Company Information, Head Office, Market Area, and Industry Position Table 121. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Models, Specifications, and Application Table 122. Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 123. Beijing Wantai Biological Pharmacy Enterprise Company Profile and Main Business Table 124. Beijing Wantai Biological Pharmacy Enterprise Recent Developments Table 125. Jiangsu Recbio Technology Company Information, Head Office, Market Area, and Industry Position Table 126. Jiangsu Recbio Technology Intramuscular HPV Vaccine Models, Specifications, and Application Table 127. Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales Quantity (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2021-2026 Table 128. Jiangsu Recbio Technology Company Profile and Main Business Table 129. Jiangsu Recbio Technology Recent Developments List of Figures Figure 1. Intramuscular HPV Vaccine Picture Figure 2. Global Intramuscular HPV Vaccine Consumption Value, (US$ million) & (2021-2032) Figure 3. Global Intramuscular HPV Vaccine Sales Quantity, (Units) & (2021-2032) Figure 4. Global Intramuscular HPV Vaccine Average Selling Price (ASP), (2021-2032) & (US$/Unit) Figure 5. Japan Intramuscular HPV Vaccine Consumption Value, (US$ million) & (2021-2032) Figure 6. Japan Intramuscular HPV Vaccine Sales Quantity (Units) & (2021-2032) Figure 7. Japan Intramuscular HPV Vaccine Average Selling Price (ASP), (US$/Unit) & (2021-2032) Figure 8. By Consumption Value, Japan Intramuscular HPV Vaccine Market Share of Global, 2021-2032 Figure 9. By Sales Quantity, Japan Intramuscular HPV Vaccine Market Share of Global, 2021-2032 Figure 10. Global Intramuscular HPV Vaccine Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2025 Figure 11. Japan Intramuscular HPV Vaccine Key Participants, Market Share, 2025 Figure 12. Global Intramuscular HPV Vaccine Capacity, Production and Capacity Utilization, 2021-2032 Figure 13. Global Intramuscular HPV Vaccine Capacity Market Share by Region, 2025 VS 2032 Figure 14. Global Intramuscular HPV Vaccine Production Market Share & Forecast by Region, 2021-2032 Figure 15. Intramuscular HPV Vaccine Industry Chain Figure 16. Intramuscular HPV Vaccine Procurement Model Figure 17. Intramuscular HPV Vaccine Sales Model Figure 18. Intramuscular HPV Vaccine Sales Channels, Direct Sales, and Distribution Figure 19. Bivalent Figure 20. Quadrivalent Figure 21. Nine-valent Figure 22. by Type, Global Intramuscular HPV Vaccine Consumption Value, 2021-2032, US$ Million Figure 23. by Type, Global Intramuscular HPV Vaccine Consumption Value Market Share, 2021-2032 Figure 24. by Type, Global Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 25. by Type, Global Intramuscular HPV Vaccine Sales Quantity Market Share, 2021-2032 Figure 26. by Type, Global Intramuscular HPV Vaccine Average Selling Price (ASP), 2021-2032, (US$/Unit) Figure 27. Male Figure 28. Female Figure 29. by Application, Global Intramuscular HPV Vaccine Consumption Value, 2021-2032, US$ Million Figure 30. by Application, Global Intramuscular HPV Vaccine Revenue Market Share, 2021-2032 Figure 31. by Application, Global Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 32. by Application, Global Intramuscular HPV Vaccine Sales Quantity Market Share, 2021-2032 Figure 33. by Application, Global Intramuscular HPV Vaccine Price, 2021-2032, (US$/Unit) Figure 34. By Region, Global Intramuscular HPV Vaccine Consumption Value Market Share, 2021-2032 Figure 35. By Region, Global Intramuscular HPV Vaccine Sales Quantity Market Share, 2021-2032 Figure 36. North America Intramuscular HPV Vaccine Consumption Value & Forecasts, 2021-2032, US$ Million Figure 37. By Country, North America Intramuscular HPV Vaccine Consumption Value Market Share, 2025 Figure 38. Europe Intramuscular HPV Vaccine Consumption Value & Forecasts, 2021-2032, US$ Million Figure 39. By Country, Europe Intramuscular HPV Vaccine Consumption Value Market Share, 2025 Figure 40. Asia Pacific Intramuscular HPV Vaccine Consumption Value & Forecasts, 2021-2032, US$ Million Figure 41. By Country/Region, Asia Pacific Intramuscular HPV Vaccine Consumption Value Market Share, 2025 Figure 42. South America Intramuscular HPV Vaccine Consumption Value & Forecasts, 2021-2032, US$ Million Figure 43. By Country, South America Intramuscular HPV Vaccine Consumption Value Market Share, 2025 Figure 44. Middle East & Africa Intramuscular HPV Vaccine Consumption Value & Forecasts, 2021-2032, US$ Million Figure 45. United States Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 46. by Type, United States Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 47. by Application, United States Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 48. Europe Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 49. by Type, Europe Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 50. by Application, Europe Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 51. China Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 52. by Type, China Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 53. by Application, China Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 54. Japan Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 55. by Type, Japan Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 56. by Application, Japan Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 57. South Korea Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 58. by Type, South Korea Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 59. by Application, South Korea Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 60. Southeast Asia Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 61. by Type, Southeast Asia Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 62. by Application, Southeast Asia Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 63. India Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 64. by Type, India Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 65. by Application, India Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 66. Middle East & Africa Intramuscular HPV Vaccine Sales Quantity, 2021-2032, (Units) Figure 67. by Type, Middle East & Africa Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 68. by Application, Middle East & Africa Intramuscular HPV Vaccine Sales Quantity Market Share, 2025 VS 2032 Figure 69. Research Methodology Figure 70. Breakdown of Primary Interviews Figure 71. Bottom-up Approaches Figure 72. Top-down Approaches
お見積>
サンプルお申込み>
今すぐ購入>
PDFダウンロード>
当社から購入のメリット
多言語（英語、日本語）のサンプル提供
プロフェッショナルな日本語翻訳を提供
請求書、クレジットカードでのお支払いが可能です
必要なチャプターやカスタマイズされたレポートの注文が可能
購入後、アナリストに直接連絡することができます
購入方法
必要な言語とバージョンのレポート選択
レポート要件と見積もり依頼
電子メールによる注文
レポートの入手（英語版は2～4営業日、日本語版は8～10営業日）
クレジットカード決済、オフライン振込に対応（後払い可）
クライアント様（例）
050-5840-2692 日本
0081-50-5840-2692 グローバル
info@globalreports.jp